共 50 条
- [33] Risankizumab maintenance therapy results in sustained improvements in endoscopic outcomes in patients with moderate to severe Crohn's Disease: Post-hoc analysis from the phase 3 study FORTIFY JOURNAL OF CROHNS & COLITIS, 2022, 16 : I127 - I128
- [34] Unbiased analysis of knee cartilage thickness change over three years after sprifermin vs. placebo treatment - A post-hoc analysis from the phase 2B FORWARD study OSTEOARTHRITIS AND CARTILAGE OPEN, 2024, 6 (04):